It looks like nothing was found at this location.

Search My-iClinic

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Request An Appointment

Fill in your details, and start your journey towards clearer vision!


Harry Orlans

Consultant and Surgeon

SPECIALTIES

EDUCATION

– BA (Hons) Physiology & Neuroscience, 1st Class, University of Cambridge (2007)
 
– BM BCh Batchelor of Medicine & Batchelor of Surgery with Distinction, University of Oxford (2010)
 
– MA (Cantab), University of Cambridge (2011)
 
– The Crombie Medal, Royal College of Ophthalmologists (2011)
 
– FRCOphth, Royal College of Ophthalmologists (2017)
 
– DPhil (PhD), University of Oxford (2019)
 
– Fellowship in Vitreoretinal Surgery, St Thomas’ Hospital, London (2020-2021)
 
– Fellowship in Vitreoretinal Surgery, Moorfields Eye Hospital, London (2022-2023)
 
– Fellowship in Medical Retina, Moorfields Eye Hospital, London (2023)
 
– AFHEA, Associate Fellow of the Higher Education Academy (2025)
 

LATEST RESEARCH

– MRC/Fight for Sight Clinical Training Research Fellowship (2015)
 
– The Founders Cup and Medal, Oxford Ophthalmological Congress (2018)
 
– MRC Developmental Pathway Funding Scheme (2020)
 
– The Ruskell Medal for Research, The Worshipful Company of Spectacle Makers (2021)
 
Zheng Q, Orlans HO, Staurenghi F, McClements ME, MacLaren RE. Design and Validation of Mirtron-Mediated RNA Interference for Gene Therapy Therapy Methods Mol Biol. 2026; 3023: 195-206.
 
Orlans HO, Yazdouni S, Williamson TH, Wong RS, Laidlaw DAH. A novel post-operative drop regimen reduces risk of ocular hypertension following pars plana vitrectomy. Ophthalmologica. 2023; 246(1):32-38.
 
Azad A, Laidlaw DAH, Orlans HO. Using QR smartphone technology to improve patient communication and information distribution. Eye 2022;26(6):1321-1322.
 
Orlans HO, McClements ME, Barnard AR, et al. Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa. Nat Commun 2021;12:4934.
 
Corazza P, D’Alterio FM, Kabbani J, Alum MMR, Mercuri S, Orlans HO, Younis S. Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study. BMC Ophthalmol 2021;21:300.
 
Xue K, Jolly JK, Barnard AR… Orlans HO et al. Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia. Nat Med 2018;24:1507–1512.

AFFILIATIONS

Fellowships and Memberships in Professional Societies
 
– Fellow of the Royal College of Ophthalmologists
 
– Member of the British & Eire Association of Vitreoretinal Surgeons (BEAVRS)
 
– Member of the European Society of Retinal Specialists (Euretina)
 
– Associate Fellow of the Higher Education Academy (Advance HE)